Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
This intro contrasts BTC and ETH to show which blockchain is easier for beginners. Learn the essential differences and how to start exploring.
20,377 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Looking for better income from corporate credit? This guide breaks down long corporate bond etfs like IGLB and VCLT, ...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
The University of Wisconsin System fired its president in a unanimous vote after a brief closed-door meeting, leaving...
In 2026, higher-income retirees still face IRMAA charges on Medicare Part D, even if their pension pays part premium....
A mega-merger and rising AI-powered data-center demand are changing how U.S. electric utilities operate. The shift is...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
The S&P 500 has climbed about 9% in 2026 amid mixed signals. This guide breaks down what Wall Street expects next, pl...
A breakthrough budget EV pickup priced at $24,950 hits the market, backed by high-profile investors. Analysts questio...
The Justice Department announced a multi-state PFAS settlement with Chemours, totaling about $450 million in penaltie...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...